Sodexo - Monthly disclosure on share capital and voting rights February 28, 2021

06 Mar 2021
www.globenewswire.com
REGULATED INFORMATION MONTHLY DISCLOSURE ON SHARE CAPITAL AND VOTING RIGHTS Pursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Issy-les-Moulineaux, March 3rd, 2021 Registered name of the issuer: SODEXO 255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUX * Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights. ** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having either single or double voting rights, including treasury shares which would normally be temporarily deprived of voting rights. About Sodexo Founded in Marseille in 1966 by Pierre Bellon, Sodexo is the global leader in services that improve Quality of Life, an essential factor in individual and organizational performance. Operating in 64 countries, Sodexo serves 100 million consumers each day through its unique combination of On‑site Services, Benefits and Rewards Services and Personal and Home Services. Sodexo provides clients an integrated offering developed over more than 50 years of experience: from foodservices, reception, maintenance and cleaning, to facilities and equipment management; from services and programs fostering employees’ engagement to solutions that simplify and optimize their mobility and expenses management, to in-home assistance, child care centers and concierge services. Sodexo’s success and performance are founded on its independence, its sustainable business model and its ability to continuously develop and engage its 420,000 employees throughout the world. Sodexo is included in the CAC Next 20, ESG 80, FTSE 4 Good et DJSI. Key figures 19.3 billion euro in Fiscal 2020 consolidated revenues 420,000 employees as at August 31, 2020 N° 1 France-based private employer worldwide 64 countries 100 million consumers served daily 12.1 billion euro market capitalization (as of March 2nd, 2021) Contacts Attachment
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.